ArticleMetabolism: clinical and experimental2026

A melanocortin 4- and glucagon-like peptide 1 receptor multiple agonist for the treatment of diabetes and obesity.

Emily F Ashlaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.